Cargando…
Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma
Gene fusions are one of the most common genomic alterations in soft tissue sarcomas (STS), which contain more than 70 subtypes. In this study, a custom‐designed RNA sequencing panel including 67 genes was developed and validated to identify gene fusions in STS. In total, 92 STS samples were analyzed...
Autores principales: | Hu, Wanming, Yuan, Li, Zhang, Xinke, Ni, Yang, Hong, Dongchun, Wang, Zhicai, Li, Xiaomin, Ling, Yuan, Zhang, Chao, Deng, Wanglong, Tian, Minqi, Ding, Ran, Song, Chao, Li, Jianmin, Zhang, Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128172/ https://www.ncbi.nlm.nih.gov/pubmed/35238118 http://dx.doi.org/10.1111/cas.15317 |
Ejemplares similares
-
Establishing an RNA fusions panel in soft tissue sarcoma with clinical validation
por: Huang, Xiaoqiang, et al.
Publicado: (2023) -
Identification of CXCL5 expression as a predictive biomarker associated with response and prognosis of immunotherapy in patients with non‐small cell lung cancer
por: Deng, Jie, et al.
Publicado: (2022) -
Whole‐exome sequencing in clear cell sarcoma of soft tissue uncovers novel prognostic categorization and drug targets
por: Li, Jingjing, et al.
Publicado: (2021) -
Time to Local Recurrence as a Predictor of Survival in Patients With Soft Tissue Sarcoma of the Extremity and Abdominothoracic Wall
por: Liang, Yao, et al.
Publicado: (2020) -
Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue Sarcoma
por: Qi, Lin, et al.
Publicado: (2021)